Press Releases :: Nighthawk Biosciences, Inc. (SCPX)

Jan 19, 2018 8:00am EST

Heat Biologics Announces Reverse Stock Split

Dec 07, 2017 7:00am EST

Heat Biologics Receives FDA Guidance at Type C Meeting for HS-110 Clinical Trial in the Treatment of Non-small Cell Lung Cancer

Nov 17, 2017 8:00am EST

Heat Biologics Prices 5,813,950 Shares for Common Stock Offering

Nov 16, 2017 4:20pm EST

Heat Biologics Announces Proposed Public Offering of Common Stock

Nov 13, 2017 7:00am EST

Heat Biologics Reports Third-quarter 2017 Results and Corporate Update

Nov 11, 2017 1:00pm EST

Heat Biologics Presents Follow-up Data on its ComPACT™ T-cell Stimulating Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Nov 06, 2017 8:00am EST

Heat Biologics to Present Data on its ComPACT Technology, at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oct 30, 2017 8:00am EDT

Pelican Therapeutics, a Subsidiary of Heat Biologics, Receives Second Tranche of its $15.2 Million CPRIT Grant Award

Oct 27, 2017 7:00am EDT

Heat Biologics Rights Offering Materials Available for Shareholders of Record

Oct 23, 2017 7:00am EDT

Heat Biologics and its Pelican Therapeutics Subsidiary Appoint Two New Members to their Scientific Advisory Boards

rss_feed News RSS